The Healthy on MSN1d
Taking an Antibiotic? Here Are the Questions to Ask Your Doctor First
Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or pharmacy.
Daily7d
FDA approves drug combination for complicated intra-abdominal infections
AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...
Renal & Urology News8d
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Pharm Exec10d
FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections
Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...
cidrap.umn11d
FDA approves combination antibiotic for difficult-to-treat infections
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...
cidrap.umn11d
WHO identifies research priorities for boosting fight against antimicrobial resistance
An additional seven research priorities focus on drug-resistant tuberculosis (TB). "The goal of this research agenda is to ...
Contract Pharma11d
AbbVie’s EMBLAVEO Approved by FDA for Treatment of Complicated Intra-Abdominal Infections
Addresses the significant threat of antimicrobial resistance.
BioSpace11d
AbbVie Gets FDA Approval for New Antibiotic in the Face of Rising Resistance
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
FiercePharma11d
AbbVie scores FDA nod for Pfizer-partnered antibiotic Emblaveo
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Pharmaceutical Technology11d
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.
Pharmabiz12d
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...